The Predictive Value of Umbilical Cord Interleukin-6: Implications for Neonatal Care-A Narrative Review of Current
Diana Iulia Vasilescu1,2, Adriana Mihaela Dan2,3, Andreea Raluca Gogoncea4
1Doctoral School, "Carol Davila" University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Insights
Elevated umbilical cord blood Interleukin-6 (IL-6) indicates higher neonatal risk for sepsis and respiratory issues. This biomarker aids in predicting outcomes and guiding clinical decisions for newborns.
Area of Science:
- Neonatal Medicine
- Biomarker Research
- Pediatric Inflammation
Background:
- Intrauterine inflammation and Fetal Inflammatory Response Syndrome (FIRS) significantly impact neonatal morbidity.
- Umbilical cord (UC) blood Interleukin-6 (IL-6) is a key indicator of intrauterine conditions and early neonatal risk.
- Accurate neonatal health assessment is critical for pediatric medicine.
Purpose of the Study:
- To review and synthesize evidence on the predictive value of UC blood IL-6 for neonatal outcomes.
- To explore the association of UC IL-6 with neonatal sepsis, respiratory distress, hypoxic-ischemic encephalopathy (HIE), and mortality.
Main Methods:
- Comprehensive literature search across PubMed, Scopus, and Web of Science.
- Narrative analysis of studies reporting UC IL-6 levels and neonatal outcomes.
- Synthesis of existing evidence on IL-6 as a neonatal biomarker.
Main Results:
- Elevated UC IL-6 is consistently linked to early-onset neonatal sepsis (EONS) and respiratory complications.
- UC IL-6 offers prognostic value for neurological outcomes.
- Factors like gestational age, delivery mode, and chorioamnionitis influence IL-6 findings.
Conclusions:
- UC IL-6 is a valuable early biomarker for neonatal risk stratification.
- IL-6 measurements support clinical decision-making in neonatal care.
- Future research should focus on standardization and prospective studies for routine integration.
Abstract:
(1) Background: The assessment of neonatal health and prognosis is one of the most critical areas in pediatric medicine. Intrauterine inflammation and the fetal inflammatory response syndrome (FIRS) are increasingly recognized as major determinants of neonatal morbidity. Interleukin-6 (IL-6), measured in the umbilical cord (UC) blood, has emerged as a promising biomarker, reflecting both intrauterine conditions and early neonatal risk. This narrative review aims to synthesize current evidence on the predictive value of umbilical cord blood IL-6 for neonatal outcome, including sepsis, respiratory distress, hypoxic-ischemic encephalopathy (HIE) and mortality. (2) Methods: A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science. Studies reporting umbilical cord IL-6 levels in relation to neonatal outcomes were analyzed and summarized narratively. (3) Results: Evidence consistently indicates that elevated umbilical cord IL-6 is associated with early-onset neonatal sepsis (EONS) and respiratory complications, and provides prognostic insight into neurological outcomes, even though results are influenced by gestational age (GA), mode of delivery, and the presence of chorioamnionitis. (4) Conclusions: UC IL-6 represents a valuable early biomarker for neonatal risk stratification and supports clinical decision-making. Future research should prioritize assay standardization, reference interval development, and prospective multicenter studies to validate its integration into routine neonatal care.
Related Concept Videos
Current Trends in Nursing II
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relationship with Parents: Attachment
Development of the Oral Microbiota


